SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple is seeing intense community volatility as the price slips below the psychological one-dollar support level, fueling a heated debate between retail investors holding for long-term utility and critics who view the asset as a failing, over-hyped project. While bulls are leveraging the dip to accumulate more tokens in anticipation of future regulatory clarity, many participants remain deeply skeptical, openly discussing the potential for further downside as they weigh the asset against broader crypto market performance.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as investors focus on strong institutional accumulation, positive management sentiment regarding pipeline acceleration, and the potential for a significant short squeeze given the substantial short interest. The community is actively discussing the company's expanding commercial footprint and upcoming clinical data catalysts as the primary drivers for a potential valuation re-rating.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending following an impressive Q2 earnings report that showed a significant shift in strategy, as the company moved from being a net seller of stocks to deploying billions into equities and accelerating share buybacks. Community discussion is polarized, with some investors celebrating the shift and the leadership of Greg Abel, while others remain skeptical, citing concerns over the company's valuation, lack of dividends, and the impact of the portfolio's cash-heavy position on long-term growth compared to the broader market.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital (NUAI) is trending as investors react to the company securing construction permits for its Texas Critical Data Centers project, marking a critical de-risking milestone. While the community remains divided over recent quarterly earnings results and the lack of a finalized tenant, bulls are aggressively pointing to the company's behind-the-meter power strategy and institutional ownership as indicators of long-term upside potential.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently trending as investors weigh strong revenue growth potential against uncertainty regarding the timing of upcoming earnings and future financing plans. Community discussion is heavily focused on the company's expansion into the sovereign AI infrastructure market, with long-term supporters highlighting the potential for a short squeeze given heavy short interest and limited share availability.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is experiencing a sharp pullback driven by investor concerns over potential off-balance-sheet financing risks and a minor security vulnerability in VMware software. While the sentiment is currently mixed due to this noise, the community remains divided between those taking advantage of the dip as a long-term buying opportunity and others frustrated by the stock's recent volatility compared to its semiconductor peers.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as investors grapple with long-term Treasury yields reaching multi-decade highs, driven by concerns over U.S. deficit spending and a potential shift in Federal Reserve policy expectations. Community discussion is polarized between those betting on a bond market capitulation to lower levels and contrarians who view current valuations as a generational buying opportunity, especially as geopolitical tensions surrounding the Strait of Hormuz continue to inject volatility into energy markets.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending amid intense debate over the firm's aggressive dilution strategy and Michael Saylor's ongoing bitcoin accumulation, with the community closely tracking regulatory news and institutional position changes. Investors remain divided, with bulls pointing to long-term treasury accumulation as a hedge while bears highlight concerns over debt obligations and potential index exclusion risks.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive Inc. (ASST) is generating intense discussion as investors monitor its capital allocation strategy, specifically the ongoing accumulation of Bitcoin against the dilution of common shares. The community remains sharply divided between bulls focused on the potential yield from its SATA preferred stock and the long-term Bitcoin treasury thesis, and skeptics who are raising concerns about the sustainability of its leverage, high-interest obligations, and the impact of frequent share issuance on shareholder value.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieve Cannabis Corp is trending as investors react to its historic NYSE uplisting and the company's concurrent share repurchase program amid the shifting regulatory landscape. Community members are actively debating the timing of potential institutional inflows and tracking upcoming DEA rescheduling hearings while navigating volatility surrounding the ticker's recent move to the exchange.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ABVC BioPharma (NASDAQ:ABVC) Trading Down 4.9% - Here's What Happened

ABVC BioPharma (NASDAQ:ABVC) Shares Down 4.9% - Here's What Happened...

ABVC BioPharma (NASDAQ:ABVC) Trading 1.6% Higher - What's Next?

ABVC BioPharma (NASDAQ:ABVC) Stock Price Up 1.6% - Time to Buy...

ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.

ABVC BioPharma Inc

Bullish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a winning week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

ABVCABVC BioPharma Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest ABVC News